Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer

Publication Date: April 26, 2021

Key Points

Key Points

  • The Panel continues to recommend that full, weight-based cytotoxic chemotherapy doses be used to treat obese adults with cancer.
  • The Panel also recommends that full, approved doses of immunotherapy and targeted therapies be offered to obese adults with cancer.
  • In the event of toxicity, the consensus of the Panel is that dose modifications of systemic antineoplastic therapies should be handled similarly for obese and non-obese patients.

Treatment

...reatment...

...ght-based dosing of cytotoxic chemothera...


...recommends limiting fixed dosing of chemotherapy...


...-approved prescribing information fo...


FDA-approved prescribing information for targete...


...ient experiences high-grade toxicity from...


...l recommends that BSA be calculated...